By expenditures
| Name | Title | Type |
|---|---|---|
| Tami Niswander | Chief Financial Officer | Auditee |
| Daniel Persaud | Principal | Auditee |
| Tami Niswander | CFO | Auditee |
| Matt Laughlin | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 367239 | 2024 | 2025-09-24 | Cliftonlarsonallen LLP | $6.17M |
| 321189 | 2023 | 2024-09-26 | Cliftonlarsonallen LLP | $10.68M |
| 22112 | 2022 | 2023-09-18 | Brady Martz & Associates PC | $4.27M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 367239 | 2024 | 2025-09-24 | 1154919 | 2024-008 | Material Weakness | Yes | I |
| 367239 | 2024 | 2025-09-24 | 1154918 | 2024-007 | Material Weakness | Yes | E |
| 367239 | 2024 | 2025-09-24 | 1154917 | 2024-006 | Material Weakness | Yes | L |
| 367239 | 2024 | 2025-09-24 | 1154916 | 2024-005 | Material Weakness | Yes | N |
| 367239 | 2024 | 2025-09-24 | 1154915 | 2024-004 | Material Weakness | Yes | N |
| 367239 | 2024 | 2025-09-24 | 1154914 | 2024-003 | Material Weakness | Yes | N |
| 367239 | 2024 | 2025-09-24 | 1154913 | 2024-007 | Material Weakness | Yes | E |
| 367239 | 2024 | 2025-09-24 | 1154912 | 2024-006 | Material Weakness | Yes | L |
| 367239 | 2024 | 2025-09-24 | 1154911 | 2024-005 | Material Weakness | Yes | N |
| 367239 | 2024 | 2025-09-24 | 1154910 | 2024-004 | Material Weakness | Yes | N |
| 367239 | 2024 | 2025-09-24 | 1154909 | 2024-003 | Material Weakness | Yes | N |
| 321189 | 2023 | 2024-09-26 | 1074927 | 2023-010 | Significant Deficiency | - | N |
| 321189 | 2023 | 2024-09-26 | 1074926 | 2023-010 | Significant Deficiency | - | N |
| 321189 | 2023 | 2024-09-26 | 1074925 | 2023-009 | Significant Deficiency | - | N |
| 321189 | 2023 | 2024-09-26 | 1074924 | 2023-009 | Significant Deficiency | - | N |
| 321189 | 2023 | 2024-09-26 | 1074923 | 2023-008 | Significant Deficiency | - | N |
| 321189 | 2023 | 2024-09-26 | 1074922 | 2023-008 | Significant Deficiency | - | N |
| 321189 | 2023 | 2024-09-26 | 1074921 | 2023-007 | Material Weakness | - | N |
| 321189 | 2023 | 2024-09-26 | 1074920 | 2023-007 | Material Weakness | - | N |
| 321189 | 2023 | 2024-09-26 | 1074919 | 2023-006 | Material Weakness | - | B |
| 321189 | 2023 | 2024-09-26 | 1074918 | 2023-005 | Material Weakness | - | L |
| 321189 | 2023 | 2024-09-26 | 1074917 | 2023-005 | Material Weakness | - | L |
| 321189 | 2023 | 2024-09-26 | 498485 | 2023-010 | Significant Deficiency | - | N |
| 321189 | 2023 | 2024-09-26 | 498484 | 2023-010 | Significant Deficiency | - | N |
| 321189 | 2023 | 2024-09-26 | 498483 | 2023-009 | Significant Deficiency | - | N |
| 321189 | 2023 | 2024-09-26 | 498482 | 2023-009 | Significant Deficiency | - | N |
| 321189 | 2023 | 2024-09-26 | 498481 | 2023-008 | Significant Deficiency | - | N |
| 321189 | 2023 | 2024-09-26 | 498480 | 2023-008 | Significant Deficiency | - | N |
| 321189 | 2023 | 2024-09-26 | 498479 | 2023-007 | Material Weakness | - | N |
| 321189 | 2023 | 2024-09-26 | 498478 | 2023-007 | Material Weakness | - | N |
| 321189 | 2023 | 2024-09-26 | 498477 | 2023-006 | Material Weakness | - | B |
| 321189 | 2023 | 2024-09-26 | 498476 | 2023-005 | Material Weakness | - | L |
| 321189 | 2023 | 2024-09-26 | 498475 | 2023-005 | Material Weakness | - | L |